Clinical Trials Directory

Trials / Completed

CompletedNCT00913588

To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fed and Fasted Conditions

Comparative, Randomized, Single-Dose, 3-way Crossover Bioavailability Study of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Health Adult Males Under Fed and Fasted Conditions Following Administration of a 40 mg Dose

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Sandoz · Industry
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

To demonstrate the relative bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride capsules (Pulvules) in healthy adult males under fed and fasted conditions.

Conditions

Interventions

TypeNameDescription
DRUGFluoxetine HCl 20 mg Capsules Under Fasting Conditions (Geneva Pharmaceutical, Inc.)
DRUGFluoxetine HCl 20 mg Capsules Under Fed Conditions (Geneva Pharmaceutical, Inc.)
DRUGProzac Fluoxetine HCl 20 mg Capsules Under Fed Conditions (Dista)

Timeline

Start date
1996-05-01
Primary completion
1996-08-01
Completion
1996-08-01
First posted
2009-06-04
Last updated
2017-03-28

Source: ClinicalTrials.gov record NCT00913588. Inclusion in this directory is not an endorsement.

To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvul (NCT00913588) · Clinical Trials Directory